Description
CJC-1295 with DAC is a synthetic growth hormone-releasing hormone (GHRH) analog featuring Drug Affinity Complex technology that extends its half-life to approximately 8 days. This 5mg peptide formulation stimulates sustained endogenous growth hormone (GH) release, supporting research in muscle development, fat metabolism, and tissue repair. The DAC modification allows for less frequent dosing while maintaining consistent GH levels, making it valuable for studying prolonged effects on body composition, recovery processes, and cellular regeneration. Researchers particularly value its extended activity profile for investigating anti-aging applications and performance enhancement protocols.
Reviews
There are no reviews yet.